Form 4: Jaguar Health Executive Steven R. King Reports Stock Transactions

Steven R. King, an executive at Jaguar Health, reported the acquisition and disposal of common stock and restricted stock units on April 5, 2024.

Summary

• On April 17, 2024, a Form 4 filing was submitted to the SEC by Lisa A. Conte, Attorney-in-Fact, on behalf of Steven R. King, Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary at Jaguar Health, Inc.
• The filing reports transactions that occurred on April 5, 2024.
• These transactions involve common stock and restricted stock units.
• King acquired 178 restricted stock units that convert into common stock on a one-for-one basis.
• King also disposed of 1,144 shares of common stock.
• The restricted stock units were granted on April 5, 2021, and vest in three equal annual installments beginning on April 5, 2022.
• The filing also references previous reverse stock splits: a 75-for-1 split on January 23, 2023, and a 3-for-1 split on September 8, 2021.
• The reported restricted stock units were adjusted to reflect these reverse stock splits.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by an insider, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand management's perspective on the company's stock.

Stakeholder Impact

• The transactions reported in the Form 4 filing may be of interest to shareholders as they provide insight into the actions of company insiders.

Key Dates

Keywords

Form 4, Jaguar Health, Steven R. King, Stock Transactions, Restricted Stock Units, Common Stock, Reverse Stock Split, SEC Filing